Galapagos NV is a clinical-stage biotechnology company. It is engaged in the discovery and development of small molecule medicines which address unmet medical conditions. This is an ADR of a company whose stock trades outside of the U.S. as the symbol NA:GLPG.
$82.57 -2.57 (-3.02%)
As of 02/26/2021 15:59:50 EST IEX book CBOE book
2021 © Stock Market MBA, Inc.